New biocomputer uses human brain cells to perform code and processing data in real time
- Advertisement -
Related Posts
- Advertisement -
- Cortical Labs offers cloud access to neuron-driven computer use for just $ 300 per week
- CL1 combines human brain cells and silicon and can perform real code
- System makes real -time neural processing possible for research in AI and neuroscience
Cortical Labs, an Australian startup We have covered earlierhas launched what it describes as the world’s first commercially available organic computer that code can perform.
The CL1 device Combines Lab cultivated human neurons with silicon hardware and is designed for neuroscience, biotech and artificial intelligence research.
Customers can buy a CL1 unit for $ 35,000 or access it remotely via a weekly rent at $ 300, where the platform is already available via Cortical Labs’ Wetware-As-a-Service.
A new way to study brain function
Each CL1 contains around 800,000 neurons that are grown from re -programmed adult cells. These neurons are kept alive by an integrated living support system that supplies nutrients and controls the environment.
The neurons communicate and adapt with the help of submillisecond electrical signals, the company says that the CL1 is able to process input and generate output almost immediately, making a new way to study brain function.
“The CL1 does this in real time with the help of simple code abstracted by several layers of firmware and hardware,” said Brett Kagan, Chief Scientific Officer at Cortical Labs Ieee spectrum. “Sub-Millisecond loops read information, act on it and write new information in the cell culture.”
The CL1 builds on Dishbrain, a proof-of-concept where neurons learned to play pong in a simulated environment.
The new model increases the input channels, improves the signal reduction and includes hardware improvements that make it more suitable for research and potential commercial applications. It has already been used to restore the learning function in neural cultures that model epilepsy.
The device consumes less power than conventional AI hardware and supports use cases, including the development of medicines, AI tests and disease modeling. It requires buyers to get ethical approval for new cell lines and to work in a laboratory environment.
Karl Friston, a theoretical neuroscientist, called the CL1 a “remarkable performance” and noted that the researchers offer a practical platform to test theories about learning, behavior and brain function with the help of real neurons.
Maybe you like it too
- Advertisement -
